Smith-Cortinez, N.; Heegsma, J.; Podunavac, M.; Zakarian, A.; Cardenas, J.C.; Faber, K.N.
Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver Fibrosis. Cells 2024, 13, 765.
https://doi.org/10.3390/cells13090765
AMA Style
Smith-Cortinez N, Heegsma J, Podunavac M, Zakarian A, Cardenas JC, Faber KN.
Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver Fibrosis. Cells. 2024; 13(9):765.
https://doi.org/10.3390/cells13090765
Chicago/Turabian Style
Smith-Cortinez, Natalia, Janette Heegsma, Masa Podunavac, Armen Zakarian, J. César Cardenas, and Klaas Nico Faber.
2024. "Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver Fibrosis" Cells 13, no. 9: 765.
https://doi.org/10.3390/cells13090765
APA Style
Smith-Cortinez, N., Heegsma, J., Podunavac, M., Zakarian, A., Cardenas, J. C., & Faber, K. N.
(2024). Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver Fibrosis. Cells, 13(9), 765.
https://doi.org/10.3390/cells13090765